Recent trends in hepatitis B virus infection in the general Korean population |
Kim, Hyuck
(Department of Internal Medicine, Kyung Hee University Medical Center)
Shin, A Ri (Department of Internal Medicine, Kyung Hee University Medical Center) Chung, Hoe Hoon (Department of Internal Medicine, Kyung Hee University Medical Center) Kim, Min Kyoung (Department of Internal Medicine, Kyung Hee University Medical Center) Lee, Ji Sung (Department of Biostatistics, Korea University College of Medicine) Shim, Jae-Jun (Department of Internal Medicine, Kyung Hee University Medical Center) Kim, Byung-Ho (Department of Internal Medicine, Kyung Hee University Medical Center) |
1 | Hepatitis B vaccines. Wkly Epidemiol Rec 2009;84:405-419. |
2 | Maynard JE. Hepatitis B: global importance and need for control. Vaccine 1990;8 Suppl:S18-S20. DOI ScienceOn |
3 | Sim JG, Seo JK, Suh SJ. Prevalence and its changes of hepatitis B viral markers from 1988 to 1993 in Korean children. J Korean Pediatr Soc 1995;38:1535-1539. |
4 | Vryheid RE, Kane MA, Muller N, Schatz GC, Bezabeh S. Infant and adolescent hepatitis B immunization up to 1999: a global overview. Vaccine 2000;19:1026-1037. DOI ScienceOn |
5 | Jang KM, Woo SH, Yun DH, et al. Seroepidemiologic survey on type B viral hepatitis in inchon area, Department of Internal Medicine, Inchon Christian Hospital. Korean J Med 1983;26:1331-1336. |
6 | Hwang EW, Cheung R. Global epidemiology of hepatitis B virus (HBV) infection. N Am J Med Sci (Boston) 2011;4:7-13. |
7 | Park NH, Chung YH, Lee HS. Impacts of vaccination on hepatitis B viral infections in Korea over a 25-year period. Intervirology 2010;53:20-28. DOI ScienceOn |
8 | Korea Centers for Disease Control and Prevention. The fifth Korea National Health and Nutrition Examination Survey (KNHANES V-1) [Internet]. Cheongwon: Korea Centers for Disease Control and Prevention, 2010 [cited 2012 May 10]. Available from: http://knhanes.cdc.go.kr. |
9 | Lin HH, Wang LY, Hu CT, et al. Decline of hepatitis B carrier rate in vaccinated and unvaccinated subjects: sixteen years after newborn vaccination program in Taiwan. J Med Virol 2003;69:471-474. DOI ScienceOn |
10 | Beasley RP, Hwang LY, Lee GC, et al. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet 1983;2:1099-1102. |
11 | Mast EE, Margolis HS, Fiore AE, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recomm Rep 2005; 54(RR-16):1-31. |
12 | Ahn YO, Kim CY, Bae SH, Chang HG. Changing pattern of HBV-related diseases in Korea since after HBV vaccination. Korean J Hepatol 2010;16(4 Suppl):S23-S37. |
13 | Han BS, Kim IS, Suh I. A study of the seroconversion rates of anti HBs and the duration of anti HBS persistence after hepatitis B vaccination. Korean J Epidemiol 1989;11:215-231. |
14 | Hwang SH, Oh HB, Kim HS, Lee EY. Evaluation of HBs Ag, HCV and HIV Ag-Ab assays using Bio-Rad elite microplate analyzer. Korean J Lab Med 2006;26:436-441. DOI ScienceOn |
15 | Chae HB, Kim JH, Kim JK, Yim HJ. Current status of liver diseases in Korea: hepatitis B. Korean J Hepatol 2009;15 Suppl 6:S13-S24. DOI ScienceOn |
16 | Jung KW, Park S, Kong HJ, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2009. Cancer Res Treat 2012;44:11-24. DOI ScienceOn |
17 | Chang MH, Shau WY, Chen CJ, et al. Hepatitis B vaccination and hepatocellular carcinoma rates in boys and girls. JAMA 2000;284:3040-3042. DOI ScienceOn |
18 | Manetta T, Gay V, Spreafico G, Massaro A, Piantino P. Instrument applications of three new Bio-Rad kits for HIV, HCV, HBSAG screening: Combo Genscreen Plus HIV 1/2 AG-AB, Monolisa anti HCV Plus V2, Monolisa HBSAG Plus, with the fully authomatic system Plato 3300. Minerva Med 2001;92:393-400. |
19 | Louisirirotchanakul S, Khupulsup K, Akraekthalin S, et al. Comparison of the technical and clinical performance of the Elecsys HBsAg II assay with the Architect, AxSym, and Advia Centaur HBsAg screening assays. J Med Virol 2010;82:755-762. DOI ScienceOn |
20 | Louisirirotchanakul S, Kanoksinsombat C, O'Charoen R, et al. HBsAg diagnostic kits in the detection of hepatitis B virus mutation within "a" determinant. Viral Immunol 2006;19:108-114. DOI ScienceOn |
21 | Xu W, Li Y, Wang M, Gu J. Comparison of two immunoassays for determining hepatitis B virus serum markers. Clin Chem Lab Med 2011;50:153-157. |
![]() |